Pharmacogenomics is a very promising branch of drug research that uses a patient's genetic profile to select appropriate medications and fine-tune drug therapies.

The Beaulieu-Saucier Pharmacogenomics Centre, which is expected to open officially in the Summer of 2007, will be built on Viau Street between Bélanger and Saint-Zotique. It will accommodate researchers and students working in major fields of pharmacogenomics.

All of the medical disciplines in the UdeM clinical network will have access to the pharmacogenomics platform as a tool for their projects. In addition, links will be established with the reputed UdeM's Centre de recherche en droit public (public law research centre) in order to set ethical rules and evaluate the social and economic impacts of the research. One of the centre's priorities will be to create a world-class clinical diagnostic laboratory.

Mr. Guy Berthiaume, Vice-Rector - Development and alumni relations, UdeM;
Mr. Robert Busilacchi, Exectuvie Director, MHI; Dr. Jean-Claude Tardif, Director, Research Centre, MHI;
Ms. Gisèle Beaulieu and Mr. Michel Saucier, Donors; Ms. France Chrétien-Desmarais, Chair of the Board of Directors, MHIF; Mr. Luc Vinet, Rector, UdeM; Mr. Jean Royer, Chair of the Board of Directors, MHI;
and Dr. Jacques Turgeon, Vice-Rector - Research, UdeM.